Cargando…

Checkpoint Inhibitor-Induced Colitis: An Update

Immunotherapy with immune checkpoint inhibitors (ICIs) nowadays has indications for several solid tumors. The current targets for ICIs are CTLA-4, PD-1, and PD-L1 receptors. Despite the clinical advantages derived from ICIs, a variety of side effects are linked to overstimulation of the immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Losurdo, Giuseppe, Angelillo, Daniele, Favia, Nicolas, Sergi, Maria Chiara, Di Leo, Alfredo, Triggiano, Giacomo, Tucci, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216810/ https://www.ncbi.nlm.nih.gov/pubmed/37239166 http://dx.doi.org/10.3390/biomedicines11051496

Ejemplares similares

Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment
por: Sergi, Maria Chiara, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis
por: Pagan, Andrea, et al.
Publicado: (2020)

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management
por: Terrin, Maria, et al.
Publicado: (2023)

Gut microbiome and checkpoint inhibitor colitis
por: Sehgal, Kanika, et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Som, Aniruddh, et al.
Publicado: (2019)

Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis
por: Ohwada, Sae, et al.
Publicado: (2022)

Inter-Observer Agreement of a New Endoscopic Score for Ulcerative Colitis Activity: Preliminary Experience
por: Principi, Mariabeatrice, et al.
Publicado: (2020)

Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
por: Barone, Michele, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
por: Perez Del Nogal, Genesis, et al.
Publicado: (2022)

Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors
por: de Andrea, Carlos Eduardo, et al.
Publicado: (2020)

Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings
por: Nishida, Tsutomu, et al.
Publicado: (2019)

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
por: Fredrick, Thomas W, et al.
Publicado: (2022)

Update on Immune Checkpoint Inhibitor Enterocolitis
por: Kelly-Goss, Molly R., et al.
Publicado: (2022)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Immune-mediated Colitis from Dual Checkpoint Inhibitors
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
por: Alorfi, Nasser M, et al.
Publicado: (2022)

Checkpoint Inhibitor Colitis With Superimposed Clostridioides difficile Infection
por: Mohammad, Al Wahadneh, et al.
Publicado: (2023)

Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors
por: Malik, Alexander, et al.
Publicado: (2023)

Checkpoint Inhibitor–Induced Colitis: A New Type of Inflammatory Bowel Disease?
por: Bertha, Madeline, et al.
Publicado: (2017)

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2018)

Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
por: Abu Khalaf, Suha, et al.
Publicado: (2020)

Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
por: Alexander, James L, et al.
Publicado: (2022)

Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
por: Zhang, Zhe, et al.
Publicado: (2022)

Severe Immune-Mediated Colitis Induced by Checkpoint Inhibitors in an Adolescent With Lynch Syndrome
por: Lee, Rachel V, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Colitis: How Long Does the Threat Last?
por: Calle Sarmiento, Paola Michelle
Publicado: (2023)

Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis
por: Hone Lopez, Sara, et al.
Publicado: (2021)

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
por: Middha, Pooja, et al.
Publicado: (2023)

Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications
por: Internò, Valeria, et al.
Publicado: (2022)

Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
por: Ierardi, Enzo, et al.
Publicado: (2019)

Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report
por: Kunogi, Yasuhito, et al.
Publicado: (2021)

Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Li, Hua, et al.
Publicado: (2021)

Dietary Considerations for Inflammatory Bowel Disease Are Useful for Treatment of Checkpoint Inhibitor-Induced Colitis
por: Saha, Aditi, et al.
Publicado: (2022)

A case of refractory immune checkpoint inhibitor‐induced colitis with Clostridioides difficile infection
por: Okura, Yukito, et al.
Publicado: (2022)

Accelerated curation of checkpoint inhibitor-induced colitis cases from electronic health records
por: Rahman, Protiva, et al.
Publicado: (2023)

Update on immune checkpoint inhibitors in gynecological cancers
por: Heong, Valerie, et al.
Publicado: (2017)

Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
por: DeCarli, Kathryn, et al.
Publicado: (2022)

Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ohrme7pe2cs7uficpbk560nbbo